Site last updated March 31, 2010 11:00 AM ET
Please be advised that all of the CDC-sponsored EUAs listed on this website are currently in effect and will remain in effect through June 23, 2010, unless the declaration of emergency is terminated or the Emergency Use Authorizations are revoked sooner or the declaration of emergency is extended. Additional information and guidance regarding EUA termination will be posted on this website closer to the eventual termination date.
Emergency Use Authorization of Relenza (zanamivir)
Content on this page was developed during the 2009-2010 H1N1 pandemic and has not been updated.
- The H1N1 virus that caused that pandemic is now a regular human flu virus and continues to circulate seasonally worldwide.
- The English language content on this website is being archived for historic and reference purposes only.
- For current, updated information on seasonal flu, including information about H1N1, see the CDC Seasonal Flu website.
- FDA-Issued Relenza EUA Letter (2.78 MB)
- Fact Sheet for Health Care Providers
- Fact Sheet for Patients and Parents/Caregivers
- *Listing of Stockpiled Antivirals at or Nearing Expiration
- Patient instructions for Diskhaler
- Package insert (222 KB)
- EUA Conditions
***Note: For information on recognizing and reporting adverse events (side effects) of Relenza, please refer to the applicable Fact Sheet.
Get email updates
To receive weekly email updates about this site, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO
